Form4insider filings, from the source

SEC Form 4 · accession 0001209191-16-125229

Aimmune Therapeutics, Inc. · AIMT

Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗

Reporting owners
Period of report
May 31, 2016
Accepted (ET)
Jun 2, 2016 · 5:40 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001631650

Table I — non-derivative securities

SecurityDateCodeSharesPriceA/DOwned afterD/INature of ownership
Common Stock, $0.0001 par valueF1May 31, 2016S120,000$15.228D3,967,900ISee Footnote
Common Stock, $0.0001 par valueF2May 31, 2016S120,000$15.228D235,020ISee Footnote

Table II — derivative securities

No Table II lines on this filing.

Explanation of responses